AzTrials
AzTrials

Children With Complex Chronic ConditionsGET2HOMENCT05568355

Garnering Effective Telehealth 2 Help Optimize Multidisciplinary Team Engagement

A study testing GET2HOME Intervention in people with Children With Complex Chronic Conditions, run by Children's Hospital Medical Center, Cincinnati at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the effectiveness of the GET2HOME Intervention bundle. Read more about this study

Who is it for?
Any age
Conditions the study is for
Children With Complex Chronic Conditions
What is being tested?
GET2HOME Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
638 participants
Where
1 siteUnited States
Study dates
1 Nov 2022to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients with complex chronic disease based on a Pediatric Medical Complexity Algorithm (PMCA) score of 3 and their families and their primary care providers
  • Discharged from pediatric hospital medicine service at our hospital

Who cannot join

  • Patients who live independently without a parent or guardian in the home, including those that live at skilled nursing facilities
  • Patients admitted for end of life care
  • Patients admitted for suicidal or homicidal ideation
  • Patients who previously enrolled in the study
  • Patients in county custody

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio, 45229

Other trials in United States

About this study

The purpose of this study is to determine the effectiveness of the GET2HOME Intervention bundle.

Being tested
GET2HOME Intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GET2HOME InterventionBehavioural

    Intervention bundle designed to improve discharge effectiveness

Study groups in NCT05568355
Study groupRoleWhat they receive
Standard Hospital-Based Care CoordinationNo interventionPatients and families randomized to this arm will receive best practice standard of care hospital-based transition planning in the hospital with routine outpatient care team follow-up post-discharge.
GET2HOME InterventionExperimentalThe GET2HOME intervention includes: 1) a pre-discharge telehealth huddle with the family, inpatient team, primary care team, and home care nursing; 2) a visual discharge task tracker (DTT) to monitor progress across care management tasks; and if desired by family and primary care 3) a post-discharge telehealth huddle 2-7 days after discharge with the family, inpatient team, primary care team, and home care nursing
Receives: Behavioral: GET2HOME Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Urgent healthcare reutilization

    Yes/no to any: unplanned hospital readmission, ED revisit, or urgent care visit

    Measured: 30-days post-discharge

Secondary outcomes (2)
  1. Global Quality of Life Scale

    Quality of Life assessment for child, caregiver and family; minimum score 0, maximum score 100; higher score means a better outcome

    Measured: 7-, 30-, 60-, and 90-days post-discharge

  2. Return to baseline

    Capturing the time it takes to return to a normal routine (family designed measure)

    Measured: 7-, 30-, 60-, and 90-days post-discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2022
  2. Study start1 Nov 2022
  3. Primary completion29 Sep 2025
  4. Study completion31 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
638 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05568355
Sponsor's protocol ID
2022-0511
Acronym
GET2HOME
Status last verified
Feb 2026
First submitted
3 Oct 2022
Last updated
4 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Warniment A, Sauers-Ford H, Brady PW, Beck AF, Callahan SR, Giambra BK, Herzog D, Huang B, Loechtenfeldt A, Loechtenfeldt L, Miller CL, Perez E, Riddle SW, Shah SS, Shepard M, Sucharew HJ, Tegtmeyer K, Thomson JE, Auger KA; GET2HOME Trial Group. Garnering effective telehealth to help optimize multidisciplinary team engagement (GET2HOME) for children with medical complexity: Protocol for a pragmatic randomized control trial. J Hosp Med. 2023 Oct;18(10):877-887. doi: 10.1002/jhm.13192. Epub 2023 Aug 21.

    PubMed 37602537

Questions about this trial

What is this clinical trial studying?

A study testing GET2HOME Intervention in people with Children With Complex Chronic Conditions, run by Children's Hospital Medical Center, Cincinnati at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Urgent healthcare reutilization (time frame: 30-days post-discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05568355, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in